Correlation Between HUTCHMED DRC and TG Therapeutics

Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HUTCHMED DRC and TG Therapeutics, you can compare the effects of market volatilities on HUTCHMED DRC and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and TG Therapeutics.

Diversification Opportunities for HUTCHMED DRC and TG Therapeutics

0.27

Correlation Coefficient

HUTCHMED DRC  TG Therapeutics

Modest diversification

The 3 months correlation between HUTCHMED and TGTX is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and TG Therapeutics go up and down completely randomly.

Pair Corralation between HUTCHMED DRC and TG Therapeutics

Considering the 90-day investment horizon HUTCHMED DRC is expected to generate 2.9 times less return on investment than TG Therapeutics. But when comparing it to its historical volatility, HUTCHMED DRC is 1.08 times less risky than TG Therapeutics. It trades about 0.05 of its potential returns per unit of risk. TG Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  3,145  in TG Therapeutics on December 28, 2024 and sell it today you would earn a total of  875.00  from holding TG Therapeutics or generate 27.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

HUTCHMED DRC  vs.  TG Therapeutics

HUTCHMED DRC

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in HUTCHMED DRC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, HUTCHMED DRC may actually be approaching a critical reversion point that can send shares even higher in April 2025.

TG Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with HUTCHMED DRC and TG Therapeutics

The main advantage of trading using opposite HUTCHMED DRC and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.

The idea behind HUTCHMED DRC and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.